Creative Planning’s Acer Therapeutics Inc ACER Stock Holding History

Creative Planning’s Portfolio ACER Stock Details ACER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-210	Closed	-$1K	–	3918
2017 Q2	$1K	Hold	210	–	–	﹤0.01%	4533
2017 Q1	$2K	Hold	210	–	–	﹤0.01%	4342
2016 Q4	$2K	Hold	210	–	–	﹤0.01%	4329
2016 Q3	$7K	Hold	210	–	–	﹤0.01%	3748
2016 Q2	$9K	Hold	210	–	–	﹤0.01%	3341
2016 Q1	$5K	Hold	210	–	–	﹤0.01%	3626
2015 Q4	$6K	Hold	210	–	–	﹤0.01%	3617
2015 Q3	$7K	Hold	210	–	–	﹤0.01%	3459
2015 Q2	$8K	Hold	210	–	–	﹤0.01%	1094
2015 Q1	$10K	Hold	210	–	–	﹤0.01%	3207
2014 Q4	$13K	Hold	210	–	–	﹤0.01%	2969
2014 Q3	$17K	Buy	+210	New	+$24.9K	﹤0.01%	2642

Other funds holding ACER

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Creative Planning's ACER Position: Q3 2017 in Review

Creative Planning sold out of Acer Therapeutics Inc (ACER) in Q3 2017, closing a stake of 210 shares — an estimated $1K sold.

Creative Planning first reported a position in ACER in Q3 2014 and held it in 12 quarters. The position peaked at $17K in Q3 2014. 4 funds tracked by Wall St. Rank hold ACER as of Q3 2017.

Creative Planning reported no remaining Acer Therapeutics Inc position as of Q3 2017 after selling out during the quarter.
Creative Planning sold 210 Acer Therapeutics Inc shares in Q3 2017, an estimated $1K.
Creative Planning first reported a position in Acer Therapeutics Inc in Q3 2014 and held it in 12 quarters.
Creative Planning's Acer Therapeutics Inc position peaked at $17K in Q3 2014.
4 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.